France
# |
Name |
Inventory |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 4.23 M
|
Dec. 31, 2023 | USD 21.38 K | 0.34% |
|
France |
|
2 |
USD 3.84 M
|
Dec. 31, 2023 | USD 0.65 | 1.19% |
|
France |
|
3 |
USD 3.46 M
|
Dec. 31, 2023 | USD 2.03 | 3.98% |
|
France |
|
4 |
USD 1.92 M
|
Dec. 31, 2023 | USD 2.06 | -0.75% |
|
France |
|
5 |
USD 1.11 M
|
Dec. 31, 2023 | USD 1.39 | 1.77% |
|
France |
|
6 |
USD 460.26 K
|
Dec. 31, 2023 | USD 2.43 | 0.68% |
|
France |
|
7 |
USD 370.86 K
|
Dec. 31, 2023 | USD 1.64 | 4.90% |
|
France |
|
8 |
USD 220.75 K
|
Dec. 31, 2023 | USD 3.47 | -1.52% |
|
France |
|
9 |
USD 209.71 K
|
Dec. 31, 2023 | USD 7.66 | 0.25% |
|
France |
|
10 |
USD 145.69 K
|
Dec. 31, 2023 | USD 5.64 | -2.27% |
|
France |
|
11 |
USD 112.58 K
|
Dec. 31, 2023 | USD 3.55 | 2.04% |
|
France |
|
12 |
USD 58.50 K
|
Dec. 31, 2023 | USD 2.58 | -11.21% |
|
France |
|
13 |
USD 4.42 K
|
Dec. 31, 2023 | USD 3.91 | 3.55% |
|
France |
|
14 |
USD 0.00
|
Dec. 31, 2023 | USD 1.45 | 1.71% |
|
France |
|
15 |
USD 0.00
|
March 31, 2024 | USD 16.83 | 1.50% |
|
France |
|
16 |
USD 0.00
|
Dec. 31, 2023 | USD 3.87 | -3.39% |
|
France |
|
17 |
USD 0.00
|
Dec. 31, 2023 | USD 2.01 | -0.78% |
|
France |
|
18 |
USD 0.00
|
Dec. 31, 2023 | USD 6.63 | -0.22% |
|
France |
|
19 |
USD 0.00
|
Dec. 31, 2023 | USD 4.22 | -0.94% |
|
France |
|
20 |
USD -1.10 K
|
Dec. 31, 2023 | USD 5.91 | -2.66% |
|
France |
The Clinical Trials company in France with the highest Inventory is Eurofins-Cerep SA (Paris Stock Exchange: ALECR.PA) at USD 4.23 M.
The Clinical Trials company in France with the lowest Inventory is ABIVAX SA (Paris Stock Exchange: ABVX.PA) at USD -1.10 K.
The top 10 Clinical Trials companies in France by Inventory are Eurofins-Cerep SA, Novacyt S.A., Crossject SA, Advicenne S.A., Valbiotis SA, Inventiva S.A., AB Science S.A., Nanobiotix S.A., MaaT Pharma SA and Adocia SA.
The bottom 10 Clinical Trials companies in France by Inventory are ABIVAX SA, DBV Technologies S.A., OSE Immunotherapeutics SA, Innate Pharma S.A., Predilife S.A., MedinCell S.A., Affluent Medical SA, Genfit S.A., Aelis Farma SA and Median Technologies SA.